The NextGen Clinical Trial Investigator Training is a virtual five-session educational program designed for investigators who currently lead or would like to lead clinical trials. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.

Timeframe: Five weeks, starting April 5 through May 3

• 5-6:30 p.m. - session program
• Additional videos to view to complete coursework

Follow the links below for speaker information at each session.

April 5 - Session 1: What is a Clinical Trial & Patient Perspective
April 12 - Session 2: Audit Ready Trials & Lessons Learned
April 19 - Session 3: Patient Recruitment & Informed Consent
April 26 - Session 4: Responsible Conduct of Research & Organizing Your Study Team
May 3 - Session 5: Institutional Resources

Session 1: What is a Clinical Trial & Patient Perspective

		Welcome—Mary Christie, Senior Director of Education – Health Affairs, Executive Vice Chancellor for Health Affairs Office, MU
		NextGen Precision Health—R. Scott Rector, PhD, Director of Roy Blunt NextGen Precision Health Building, Associate Professor, Nutrition & Exercise Physiology, MU Washington University Institute of Clinical and Translational Sciences—Bill Powderly, MD, Associate Dean for Clinical and Translational Sciences, Washington University in St. Louis
		What is a Clinical Trial?—Parvesh Kumar, MD, Associate Dean of Clinical & Translational Research, MU School of Medicine New Investigator Manual—Matthew Macaluso, DO, Bee McWane Reid Professor and Clinical Director, Depression and Suicide Center, University of Alabama at Birmingham
		Patient Perspective—Kim Kimminau, PhD, Chief of Staff and Chief of Planning for the Executive Vice Chancellor for Health Affairs Office, MU, and Jeff Ordway, Patient Research Advocate, MU